Best treatments for peripheral t-cell lymphoma
3 products may treat peripheral t-cell lymphoma, spanning FDA drug classes such as histone deacetylase inhibitor, folate analog metabolic inhibitor. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for peripheral t-cell lymphoma, none are yet flagged as generics in our price data, spanning classes such as histone deacetylase inhibitor, folate analog metabolic inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for peripheral t-cell lymphoma — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Injectable | Histone Deacetylase Inhibitor | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | Folate Analog Metabolic Inhibitor | No data | — | View → | |
| 3 | Not yet rated | Prescription | Kit | Histone Deacetylase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: histone deacetylase inhibitor
Full ranking · 3 treatments
beleodaq
PrescriptionFDA-sourced
Beleodaq (Belinostat) is a histone deacetylase inhibitor used to treat Peripheral T-Cell Lymphoma.
Price varies
folotyn
PrescriptionFDA-sourced
Folotyn (Pralatrexate) is a folate analog metabolic inhibitor used to treat Peripheral T-Cell Lymphoma.
Price varies
istodax
PrescriptionFDA-sourced
Istodax (Romidepsin) is a histone deacetylase inhibitor used to treat Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma.
Price varies
Frequently asked
- What treats peripheral t-cell lymphoma?
- Our catalog lists 3 products that may treat peripheral t-cell lymphoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for peripheral t-cell lymphoma?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat peripheral t-cell lymphoma.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat peripheral t-cell lymphoma?
- Treatments for peripheral t-cell lymphoma span FDA drug classes including histone deacetylase inhibitor, folate analog metabolic inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status